Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Individual variation in incentive salience attribution and accumbens dopamine transporter expression and function.

Singer BF, Guptaroy B, Austin CJ, Wohl I, Lovic V, Seiler JL, Vaughan RA, Gnegy ME, Robinson TE, Aragona BJ.

Eur J Neurosci. 2016 Mar;43(5):662-70. doi: 10.1111/ejn.13134. Epub 2016 Jan 7.

PMID:
26613374
2.

Meta-analysis reveals significant association of 3'-UTR VNTR in SLC6A3 with smoking cessation in Caucasian populations.

Ma Y, Yuan W, Cui W, Li MD.

Pharmacogenomics J. 2016 Feb;16(1):10-7. doi: 10.1038/tpj.2015.44. Epub 2015 Jul 7.

3.

Genetic variation of the dopamine transporter (DAT1) influences the acute subjective responses to cocaine in volunteers with cocaine use disorders.

Brewer AJ 3rd, Nielsen DA, Spellicy CJ, Hamon SC, Gingrich J, Thompson-Lake DG, Nielsen EM, Mahoney JJ 3rd, Kosten TR, Newton TF, De La Garza R 2nd.

Pharmacogenet Genomics. 2015 Jun;25(6):296-304. doi: 10.1097/FPC.0000000000000137.

4.

Dopaminergic control of cognitive flexibility in humans and animals.

Klanker M, Feenstra M, Denys D.

Front Neurosci. 2013 Nov 5;7:201. doi: 10.3389/fnins.2013.00201. Review.

5.

DAT1 polymorphism is associated with risk taking in the Balloon Analogue Risk Task (BART).

Mata R, Hau R, Papassotiropoulos A, Hertwig R.

PLoS One. 2012;7(6):e39135. doi: 10.1371/journal.pone.0039135. Epub 2012 Jun 18.

6.

Neurogenetics of depression: a focus on reward processing and stress sensitivity.

Bogdan R, Nikolova YS, Pizzagalli DA.

Neurobiol Dis. 2013 Apr;52:12-23. doi: 10.1016/j.nbd.2012.05.007. Epub 2012 Jun 1. Review.

7.

Genetically determined dopamine availability predicts disposition for depression.

Felten A, Montag C, Markett S, Walter NT, Reuter M.

Brain Behav. 2011 Nov;1(2):109-18. doi: 10.1002/brb3.20.

8.

Imaging genetics and the neurobiological basis of individual differences in vulnerability to addiction.

Sweitzer MM, Donny EC, Hariri AR.

Drug Alcohol Depend. 2012 Jun;123 Suppl 1:S59-71. doi: 10.1016/j.drugalcdep.2012.01.017. Epub 2012 Feb 16. Review.

9.

Genotype and ancestry modulate brain's DAT availability in healthy humans.

Shumay E, Chen J, Fowler JS, Volkow ND.

PLoS One. 2011;6(8):e22754. doi: 10.1371/journal.pone.0022754. Epub 2011 Aug 3.

10.

Effect of dopamine transporter genotype on caudate volume in childhood ADHD and controls.

Shook D, Brady C, Lee PS, Kenealy L, Murphy ER, Gaillard WD, VanMeter JW, Cook EH Jr, Stein M, Vaidya CJ.

Am J Med Genet B Neuropsychiatr Genet. 2011 Jan;156B(1):28-35. doi: 10.1002/ajmg.b.31132. Epub 2010 Oct 18.

11.

Genetic determinants of time perception mediated by the serotonergic system.

Sysoeva OV, Tonevitsky AG, Wackermann J.

PLoS One. 2010 Sep 17;5(9). pii: e12650. doi: 10.1371/journal.pone.0012650.

12.

Dopamine transporter genotype predicts implicit sequence learning.

Simon JR, Stollstorff M, Westbay LC, Vaidya CJ, Howard JH Jr, Howard DV.

Behav Brain Res. 2011 Jan 1;216(1):452-7. doi: 10.1016/j.bbr.2010.08.043. Epub 2010 Sep 8.

13.

Dopamine transporter (SLC6A3) genotype impacts neurophysiological correlates of cognitive response control in an adult sample of patients with ADHD.

Dresler T, Ehlis AC, Heinzel S, Renner TJ, Reif A, Baehne CG, Heine M, Boreatti-Hümmer A, Jacob CP, Lesch KP, Fallgatter AJ.

Neuropsychopharmacology. 2010 Oct;35(11):2193-202. doi: 10.1038/npp.2010.91. Epub 2010 Jul 14.

14.

The dopamine transporter gene, a spectrum of most common risky behaviors, and the legal status of the behaviors.

Guo G, Cai T, Guo R, Wang H, Harris KM.

PLoS One. 2010 Feb 22;5(2):e9352. doi: 10.1371/journal.pone.0009352.

15.

Neural response to working memory load varies by dopamine transporter genotype in children.

Stollstorff M, Foss-Feig J, Cook EH Jr, Stein MA, Gaillard WD, Vaidya CJ.

Neuroimage. 2010 Nov 15;53(3):970-7. doi: 10.1016/j.neuroimage.2009.12.104. Epub 2010 Jan 4.

16.

Dopamine transporter gene variation modulates activation of striatum in youth with ADHD.

Bédard AC, Schulz KP, Cook EH Jr, Fan J, Clerkin SM, Ivanov I, Halperin JM, Newcorn JH.

Neuroimage. 2010 Nov 15;53(3):935-42. doi: 10.1016/j.neuroimage.2009.12.041. Epub 2009 Dec 21.

17.

The role of the dopamine transporter (DAT) in the development of PTSD in preschool children.

Drury SS, Theall KP, Keats BJ, Scheeringa M.

J Trauma Stress. 2009 Dec;22(6):534-9. doi: 10.1002/jts.20475.

18.

Influences of polymorphic variants of DRD2 and SLC6A3 genes, and their combinations on smoking in Polish population.

Sieminska A, Buczkowski K, Jassem E, Niedoszytko M, Tkacz E.

BMC Med Genet. 2009 Sep 17;10:92. doi: 10.1186/1471-2350-10-92.

19.

Dopamine genes and nicotine dependence in treatment-seeking and community smokers.

Bergen AW, Conti DV, Van Den Berg D, Lee W, Liu J, Li D, Guo N, Mi H, Thomas PD, Lessov-Schlaggar CN, Krasnow R, He Y, Nishita D, Jiang R, McClure JB, Tildesley E, Hops H, Tyndale RF, Benowitz NL, Lerman C, Swan GE.

Neuropsychopharmacology. 2009 Sep;34(10):2252-64. doi: 10.1038/npp.2009.52. Epub 2009 Jun 3.

20.

Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

Haile CN, Kosten TR, Kosten TA.

Am J Drug Alcohol Abuse. 2009;35(3):161-77. doi: 10.1080/00952990902825447. Review.

Items per page

Supplemental Content

Write to the Help Desk